Here are some of the top stories on Healio.com/OSN this week:
Notice of allowance for patent on corneal wound treatment issued to RegeneRx
RegeneRx Biopharmaceuticals has been issued a notice of allowance by the U.S. Patent and Trademark Office for a new patent for treating corneal wounds using thymosin beta 4 or related therapeutic peptides. Read more.
Training time adds minutes to patient encounters
The amount of time an attending ophthalmologist spends in a room with a patient is longer when a trainee is present, even when the (Read more...)
Uncategorized